In BC, PIK3Ca mutations tend to be associated with hormone receptor-positive tumours, and a study carried out by Lau et al. has provided further evidence of the importance of PIK3Ca mutations in metabolic reprogramming, specifically increasing glutamine uptake and glutamate production by modulating pyruvate dehydrogenase activity [33]. This evidence concerns the gene PIK3CA and neoplasm.